Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 AB INBEV ABI Oct 15, 2021 47.91 -1.61   
 ABO-Group ABO Oct 15, 2021 5.35 0.00   
 Acacia Pharma Group Plc ACPH Oct 15, 2021 1.76 -3.30   
 Accentis S.A. ACCB Oct 15, 2021 0.06 +5.00   
 Ackermans & van Haaren NV ACKB Oct 15, 2021 148.90 +0.20   
 Aedifica SA AED Oct 15, 2021 114.20 +0.35   
 Ageas AGS Oct 15, 2021 40.97 +0.61   
 AGFA-Gevaert NV AGFB Oct 15, 2021 3.69 -1.73   
 AHOLD DEL AD Oct 15, 2021 27.95 +0.23   
 Antares Certificates ANT Oct 15, 2021 8.40 0.00   
 APERAM APAM Oct 15, 2021 49.34 +2.11   
 Argen X SE ARGX Oct 15, 2021 255.30 -1.47   
 Ascencio Sca ASC Oct 15, 2021 49.90 +0.10   
 ASIT biotech SA ASIT Oct 15, 2021 0.31 +1.95   
 Assicurazioni Generali SpA GEN Oct 15, 2021 18.52 0.00   
 Atenor ATEB Oct 15, 2021 59.20 +2.07   
 AVANTIUM AVTX Oct 15, 2021 4.03 +3.20   
 Balta Group N.V. BALTA Oct 15, 2021 2.75 +1.85   
 Banco Bilbao Vizcaya Argentaria SA BBV Oct 15, 2021 6.35 0.00   
 Banco Santander SA SANTA Oct 15, 2021 3.40 +2.88   
 Banimmo BANI Oct 15, 2021 3.28 +1.23   
 Banque Nationale de Belgique BNB Oct 15, 2021 1 705.00 -0.29   
 Barco NV BAR Oct 15, 2021 18.47 -0.75   
 Basilix BAS Oct 15, 2021 11.20 0.00   
 Beaulieu Av Certificates BEAB Oct 15, 2021 6.00 0.00   
 Befimmo SA BEFB Oct 15, 2021 35.35 -0.42   
 Bel20 BEL20 Oct 15, 2021 4 205.30 +0.05   
 Belreca - Belgian Resources and Capital Company BELR Oct 15, 2021 158.00 0.00   
 Beluga BELU Oct 15, 2021 2.56 +1.59   
 Biocartis Group NV BCART Oct 15, 2021 3.83 +0.13   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK